Versor Investments LP Invests $822,000 in Colgate-Palmolive Company $CL

Versor Investments LP purchased a new stake in shares of Colgate-Palmolive Company (NYSE:CL) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 10,282 shares of the company’s stock, valued at approximately $822,000.

Other institutional investors and hedge funds have also modified their holdings of the company. ProShare Advisors LLC boosted its holdings in Colgate-Palmolive by 11.0% in the third quarter. ProShare Advisors LLC now owns 2,047,542 shares of the company’s stock worth $163,681,000 after purchasing an additional 202,379 shares during the last quarter. Asset Management One Co. Ltd. boosted its stake in shares of Colgate-Palmolive by 3.9% in the 3rd quarter. Asset Management One Co. Ltd. now owns 422,292 shares of the company’s stock worth $33,758,000 after buying an additional 16,017 shares during the last quarter. Cidel Asset Management Inc. grew its holdings in shares of Colgate-Palmolive by 13.6% in the second quarter. Cidel Asset Management Inc. now owns 329,060 shares of the company’s stock worth $29,912,000 after acquiring an additional 39,413 shares during the period. Vanguard Group Inc. lifted its holdings in Colgate-Palmolive by 1.2% in the second quarter. Vanguard Group Inc. now owns 82,751,689 shares of the company’s stock valued at $7,522,129,000 after acquiring an additional 993,432 shares during the period. Finally, TD Waterhouse Canada Inc. lifted its holdings in Colgate-Palmolive by 248.5% in the third quarter. TD Waterhouse Canada Inc. now owns 87,410 shares of the company’s stock valued at $6,909,000 after acquiring an additional 62,327 shares during the period. Institutional investors own 80.41% of the company’s stock.

Insider Activity at Colgate-Palmolive

In other news, insider Sally Massey sold 15,851 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $95.03, for a total value of $1,506,320.53. Following the completion of the transaction, the insider owned 13,751 shares in the company, valued at approximately $1,306,757.53. The trade was a 53.55% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Stanley J. Sutula III sold 97,843 shares of the firm’s stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total value of $9,223,659.61. Following the completion of the sale, the chief financial officer owned 55,310 shares of the company’s stock, valued at approximately $5,214,073.70. This represents a 63.89% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.41% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several research firms have recently commented on CL. Deutsche Bank Aktiengesellschaft upped their price target on shares of Colgate-Palmolive from $83.00 to $90.00 and gave the company a “hold” rating in a research report on Monday, February 2nd. Bank of America increased their price target on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a research report on Monday, February 2nd. Barclays upped their price objective on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 3rd. Weiss Ratings reiterated a “hold (c)” rating on shares of Colgate-Palmolive in a research report on Wednesday, January 21st. Finally, Jefferies Financial Group raised their price objective on Colgate-Palmolive from $85.00 to $91.00 and gave the stock a “hold” rating in a research note on Monday, February 2nd. Eleven equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and a consensus target price of $94.47.

Colgate-Palmolive Stock Performance

Shares of NYSE CL opened at $93.98 on Wednesday. The firm’s fifty day moving average is $82.72 and its two-hundred day moving average is $81.63. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $100.18. The company has a market cap of $75.75 billion, a P/E ratio of 35.87, a P/E/G ratio of 4.25 and a beta of 0.29. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.27 and a current ratio of 0.42.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. The firm had revenue of $5.23 billion during the quarter, compared to analyst estimates of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The business’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same quarter last year, the business posted $0.91 earnings per share. As a group, analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st will be given a dividend of $0.52 per share. The ex-dividend date is Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a yield of 2.2%. Colgate-Palmolive’s dividend payout ratio is 79.39%.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.